The College of American Pathologists (CAP) expressed strong support for the legislation, warning that continued fee reductions under PAMA would threaten patient care. “The CAP supports congressional efforts to improve the PAMA rate-setting process for clinical lab services and reduce unnecessary burdens on laboratories,” said CAP president Donald S. Karcher, MD, FCAP.
For the full article click here: Bipartisan Lawmakers, Lab Leaders Back RESULTS Act to Protect Medicare Patients’ Access to Testing